(Q38006283)

26 August 2017

title

The 'complexities' of life and death: death receptor signalling platforms (English)

1 reference

26 August 2017

Laura S Dickens

1

1 reference

26 August 2017

Ian R Powley

series ordinal

2

1 reference

26 August 2017

Michelle A Hughes

series ordinal

3

1 reference

26 August 2017

Marion MacFarlane

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

17 April 2012

1 reference

Experimental Cell Research

26 August 2017

published in

1 reference

26 August 2017

volume

318

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

1269-1277

1 reference

Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Identification of Modulators of TRAIL-Induced Apoptosis via RNAi-Based Phenotypic Screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The TNF and TNF receptor superfamilies: integrating mammalian biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The molecular architecture of the TNF superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Solution NMR Investigation of the CD95/FADD Homotypic Death Domain Complex Suggests Lack of Engagement of the CD95 C Terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The Fas-FADD death domain complex structure unravels signalling by receptor clustering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

FADD self-association is required for stable interaction with an activated death receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The structure of FADD and its mode of interaction with procaspase-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Requirement of cooperative functions of two repeated death effector domains in caspase-8 and in MC159 for induction and inhibition of apoptosis, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

CD95 stimulation results in the formation of a novel death effector domain protein-containing complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Tumor necrosis factor signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Fas-associated Death Domain Protein and Caspase-8 Are Not Recruited to the Tumor Necrosis Factor Receptor 1 Signaling Complex during Tumor Necrosis Factor-induced Apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

TNF-alpha induces two distinct caspase-8 activation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

A unified model for apical caspase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Insights into the regulatory mechanism for caspase-8 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Inhibition of fas death signals by FLIPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

c-FLIPR, a new regulator of death receptor-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The role of c-FLIP in modulation of CD95-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Inhibition of death receptor signals by cellular FLIP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Antigen-mediated T cell expansion regulated by parallel pathways of death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Mechanisms of necroptosis in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Programmed cell death: Apoptosis meets necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Caspase 8 inhibits programmed necrosis by processing CYLD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Identification of RIP1 kinase as a specific cellular target of necrostatins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Many stimuli pull the necrotic trigger, an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Virus inhibition of RIP3-dependent necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Immunogenic cell death modalities and their impact on cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Necrostatin: a potentially novel cardioprotective agent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.04.005

10.1016/J.YEXCR.2012.04.005

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference